What is Promimic?
Promimic specializes in the development and application of advanced nanotechnology designed to optimize implant surfaces. Their flagship product, HAnano Surface, is engineered to significantly enhance osseointegration and accelerate bone growth, addressing critical challenges in orthopedic and dental surgery. With a track record validated by over 30 clinical studies and implementation in more than 150,000 cases, the company has established itself as a leader in surface science. By serving a diverse clientele that spans dental professionals, orthopedic surgeons, and partners in the biosensors and oncology fields, Promimic provides technically superior solutions that directly improve patient outcomes and implant longevity. Their market position is defined by a commitment to rigorous scientific validation and high-performance material engineering.
How much funding has Promimic raised?
Promimic has raised a total of $13.2M across 2 funding rounds:
Unspecified
$10M
Private Equity
$3.2M
Unspecified (2011): $10M with participation from Almi Foretags
Private Equity (2016): $3.2M led by Chalmers Ventures
Key Investors in Promimic
Almi Foretags
Almi provides financing in the form of loans and venture capital, as well as support and guidance in business development for small and medium-sized enterprises in Sweden.
Chalmers Ventures
Chalmers Ventures is a leading tech investor and venture builder in the Nordics, specializing in transforming deep tech from lab to market.
What's next for Promimic?
Following this major strategic investment, Promimic is well-positioned to transition into a new phase of enterprise-level expansion. The company is expected to leverage this capital to deepen its research and development capabilities, potentially exploring new applications for its nanotechnology in emerging medical fields. By focusing on scaling its manufacturing processes and expanding its global distribution network, Promimic aims to solidify its status as the industry standard for bioactive implant surfaces. Future growth will likely be driven by continued clinical validation and strategic partnerships that integrate their surface technology into a broader range of medical devices, ensuring long-term value creation for stakeholders and improved clinical results for patients worldwide.
See full Promimic company page
